YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) 26% Jump Shows Its Popularity With Investors
May 12
Have your own idea? Try our Stock Screener
Hong Kong (HSI) Pharma Industry Analysis
UpdatedMay 14, 2025
DataAggregated Company Financials
Companies39
- 7D-2.5%
- 3M19.4%
- 1Y5.2%
- YTD18.9%
Over the last 7 days, the Pharma industry has dropped 3.8%, driven by a pullback from Hansoh Pharmaceutical Group of 8.2%. Meanwhile, Grand Pharmaceutical Group actually outperformed within the industry, gaining 38% in the last week. Over the past 12 months, the industry was up 4.1%. As for the next few years, earnings are expected to grow by 11% per annum.
Industry Valuation and Performance
Has the Hong Kong Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 14 May 2025 | HK$496.4b | HK$474.4b | HK$29.0b | 10.9x | 17.1x | 1x |
| Fri, 11 Apr 2025 | HK$461.5b | HK$464.6b | HK$28.5b | 9.6x | 16.2x | 1x |
| Sun, 09 Mar 2025 | HK$452.3b | HK$464.2b | HK$31.9b | 8.6x | 14.2x | 1x |
| Tue, 04 Feb 2025 | HK$410.1b | HK$464.7b | HK$32.0b | 8.4x | 12.8x | 0.9x |
| Thu, 02 Jan 2025 | HK$433.4b | HK$460.1b | HK$31.7b | 8.6x | 13.7x | 0.9x |
| Sat, 30 Nov 2024 | HK$444.3b | HK$463.1b | HK$31.5b | 8.1x | 14.1x | 1x |
| Mon, 28 Oct 2024 | HK$482.4b | HK$470.9b | HK$32.7b | 7.9x | 14.7x | 1x |
| Wed, 25 Sep 2024 | HK$449.4b | HK$477.4b | HK$33.1b | 7.7x | 13.6x | 0.9x |
| Fri, 23 Aug 2024 | HK$430.9b | HK$464.8b | HK$30.7b | 6.9x | 14x | 0.9x |
| Sun, 21 Jul 2024 | HK$430.5b | HK$457.8b | HK$32.5b | 7.5x | 13.2x | 0.9x |
| Tue, 18 Jun 2024 | HK$461.6b | HK$463.1b | HK$33.9b | 8.3x | 13.6x | 1x |
| Thu, 16 May 2024 | HK$488.4b | HK$464.0b | HK$33.8b | 8.9x | 14.5x | 1.1x |
| Sat, 13 Apr 2024 | HK$440.7b | HK$464.9b | HK$33.8b | 7.6x | 13x | 0.9x |
| Mon, 11 Mar 2024 | HK$439.1b | HK$470.9b | HK$33.5b | 8x | 13.1x | 0.9x |
| Wed, 07 Feb 2024 | HK$418.0b | HK$473.1b | HK$33.9b | 6.7x | 12.3x | 0.9x |
| Fri, 05 Jan 2024 | HK$489.9b | HK$472.2b | HK$33.7b | 8.2x | 14.5x | 1x |
| Sun, 03 Dec 2023 | HK$506.1b | HK$472.6b | HK$33.8b | 7.5x | 15x | 1.1x |
| Tue, 31 Oct 2023 | HK$483.0b | HK$469.0b | HK$31.5b | 6.7x | 15.3x | 1x |
| Thu, 28 Sep 2023 | HK$438.8b | HK$469.1b | HK$31.5b | 6.8x | 13.9x | 0.9x |
| Sat, 26 Aug 2023 | HK$424.2b | HK$448.9b | HK$30.7b | 7.8x | 13.8x | 0.9x |
| Mon, 24 Jul 2023 | HK$475.5b | HK$446.5b | HK$27.9b | 9x | 17.1x | 1.1x |
| Wed, 21 Jun 2023 | HK$511.3b | HK$446.9b | HK$27.7b | 9.6x | 18.5x | 1.1x |
| Fri, 19 May 2023 | HK$527.3b | HK$450.1b | HK$28.1b | 8.8x | 18.8x | 1.2x |
| Sun, 16 Apr 2023 | HK$581.9b | HK$454.1b | HK$28.9b | 9.2x | 20.2x | 1.3x |
| Tue, 14 Mar 2023 | HK$613.2b | HK$444.3b | HK$34.2b | 9.9x | 18x | 1.4x |
| Thu, 09 Feb 2023 | HK$619.7b | HK$447.7b | HK$35.7b | 11.3x | 17.4x | 1.4x |
| Sat, 07 Jan 2023 | HK$625.9b | HK$445.4b | HK$35.3b | 11.6x | 17.7x | 1.4x |
| Mon, 05 Dec 2022 | HK$588.5b | HK$440.5b | HK$34.5b | 9.4x | 17.1x | 1.3x |
| Wed, 02 Nov 2022 | HK$597.2b | HK$509.5b | HK$37.6b | 8.5x | 15.9x | 1.2x |
| Fri, 30 Sep 2022 | HK$493.6b | HK$511.4b | HK$39.7b | 8.7x | 12.4x | 1x |
| Sun, 28 Aug 2022 | HK$568.9b | HK$522.9b | HK$43.6b | 8.5x | 13x | 1.1x |
| Tue, 26 Jul 2022 | HK$611.4b | HK$512.8b | HK$51.9b | 8.1x | 11.8x | 1.2x |
| Thu, 23 Jun 2022 | HK$602.4b | HK$515.0b | HK$52.0b | 9.4x | 11.6x | 1.2x |
| Sat, 21 May 2022 | HK$586.0b | HK$512.6b | HK$51.9b | 8.8x | 11.3x | 1.1x |
Price to Earnings Ratio
11.3x
Current Industry PE
- Investors are optimistic on the Hong Kong Pharmaceuticals industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 17.1x which is higher than its 3-year average PE of 14.7x.
- The industry is trading close to its 3-year average PS ratio of 1.1x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have declined 18% per year over the last three years,
- Revenues have also declined 2.6% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the Hong Kong Healthcare industry?
| HK Market | 2.09% | |
| Healthcare | -3.00% | |
| Pharma | -2.52% | |
| Pharma | -2.52% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 512 Grand Pharmaceutical Group | HK$8.29 | 38.4% +HK$8.1b | 66.1% | PE11.8x | |
| 570 China Traditional Chinese Medicine Holdings | HK$2.09 | 2.5% +HK$251.8m | -51.4% | PE179.8x | |
| 1558 YiChang HEC ChangJiang Pharmaceutical | HK$13.10 | 1.9% +HK$211.2m | 9.0% | PE22.1x | |
| 1666 Tong Ren Tang Technologies | HK$4.93 | 2.7% +HK$166.5m | -14.9% | PE11.2x | |
| 8049 Jilin Province Huinan Changlong Bio-pharmacy | HK$2.05 | 9.6% +HK$100.8m | 41.4% | PE5.8x |
